ESGE and ESGENA Position Statement on gastrointestinal endoscopy and the COVID-19 pandemic.

"Competing interests I. M. Gralnek has received lecture fees from Astra-Zeneca, Taro Pharma, Vifor Pharma and 3D Matrix (ongoing); consultant fees from Boston Scientific, GI view, Motus GI and Symbionix (ongoing); and is DSMB Member by Intec Pharma, MAB member by Motus GI. J. E. van Hooft has received lecture fees from Medtronics (2014 – 2015) and Cook Medical (2019), and consultancy fees from Boston Scientific (2014 – 2017); her department has received research grants from Cook Medical (2014 – 2019) and Abbott (2014 – 2017). M. Kaminski has received lecture fees from Boston Scientific (2018 – ongoing) and consultancy fees from Olympus and Fujifilm (2018-ongoing). P. D. Siersema has received research grants from Norgine, Pentax, Microtech, Yakult and Motus GI (ongoing) and is on the Advisory Board of Motus GI. G. Antonelli, C. Hassan, A. Ebigbo, M. Pellisé, M. Arvanitakis, P. Bhandari, R. Bisschops, K. Triantafyllou, G. Webster, H. Pohl, T. Ponchon, H. Messmann, M. Dinis-Ribeiro have no competing interest."